Recombinant Human Erythropoietin in the Treatment of Human Brain Disease: Focus on Cognition
- 31 January 2008
- journal article
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 18 (1) , 146-153
- https://doi.org/10.1053/j.jrn.2007.10.029
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietinBiochemical and Biophysical Research Communications, 2005
- Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root gangliaBrain Structure and Function, 2005
- Emerging biological roles for erythropoietin in the nervous systemNature Reviews Neuroscience, 2005
- A novel endogenous erythropoietin mediated pathway prevents axonal degenerationAnnals of Neurology, 2004
- The role of erythropoietin in regulating angiogenesisDevelopmental Biology, 2004
- Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblastsNeuroscience Letters, 2004
- Expression patterns of erythropoietin and its receptor in the developing midbrainBrain Structure and Function, 2004
- Erythropoietin Prevents Place Navigation Disability and Cortical Infarction in Rats with Permanent Occlusion of the Middle Cerebral ArteryBiochemical and Biophysical Research Communications, 1998
- Oxygen Sensing in the Kidney and its Relation to Erythropoietin ProductionAnnual Review of Physiology, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987